Records containing: Mucopolysaccharidosis Type II
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-07-30Multicenter, Open-Label, Multi-cohort Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Drug Product GNR 055 (JSC "GENERIUM", Russia) in Patients With Mucopolysaccharidosis Type II
-
CLINICAL_TRIALS study record update · 2024-07-03Open-label Multi-cohort Study of the Tolerability, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers After a Single Intravenous Injection in Increasing Doses
-
CLINICAL_TRIALS study record update · 2023-09-01COHERE - Core Outcome Set for Head, Neck and Respiratory Disease in Mucopolysaccharidosis II
-
CLINICAL_TRIALS study record update · 2020-10-14An Open-label Multi-cohort Dose-escalation Study to Evaluate the Tolerance, Safety, and Pharmacokinetics of GNR-055 (GENERIUM JSC, Russia) in Healthy Volunteers With a Single Intravenous Administration
-
CLINICAL_TRIALS study record update · 2019-09-06Longitudinal Studies of Brain Structure and Function in MPS Disorders
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-12-13Behavioral Challenges in Children With Mucopolysaccharidosis Type I-III and Parental Coping Strategies
-
CLINICAL_TRIALS study record update · 2017-09-15Pilot Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II and VI